Hepatocellular Carcinoma in HIV-infected Individuals in Asian Population
Hepatocellular Carcinoma in HIV-infected Individuals in Asian Population
This is a retrospective study, all HIV-infected individuals followed up at the three
 designated HIV clinics in Hong Kong with and without HBV and/or HCV co-infection will be
 included in the analysis. The incidence and mortality of HCC among HIV-infected individuals
 with and without HBV/HCV co-infection in an Asian population will be determined.
The incidence of hepatocellular carcinoma (HCC) is increasing over time among the
 HIV-infected population, and is an increasingly important cause of morbidity and mortality in
 HIV-infected individuals. Despite effective treatment for HBV and HCV infections, HCC is
 still reported in treated HIV-infected individuals with HBV/HCV co-infections. Currently,
 data on the risk and outcomes of HCC in HIV infected populations in Asia is lacking. This
 study aims to evaluate the incidence of HCC in HIV-infected individuals with and without
 HBV/HCV co-infection, and HBV/HCV mono-infected individuals in Hong Kong.

 This is a retrospective study, all HIV-infected individuals followed up at the three
 designated HIV clinics in Hong Kong with and without HBV and/or HCV co-infection will be
 included in the analysis. The burden of HCC among HIV-infected individuals with and without
 HBV/HCV co-infection in an Asian population will be determined by comparing their incidence
 and mortality.

 Objectives:

 1. To determine the burden of HCC among HIV-infected individuals with and without HBV/HCV
 co-infection in an Asian population

 2. To compare the incidence of HCC between HIV-infected individuals with HBV/HCV
 co-infection and HIV-uninfected individuals with HBV or HCV-monoinfection

 3. To compare the mortality rate of HCC between HIV-infected individuals with HBV/HCV co-
 infection and HIV-uninfected individuals with HBV or HCV-monoinfection.

 Study procedures

 1. The electronic databases and medical records of all three HIV centres, and Clinical Data
 Analysis and Reporting System (CDARS) will be reviewed for data extraction for
 HIV-infected individuals.

 2. The medical records and electronic database of Hospital Authority, Clinical Data
 Analysis and Reporting System (CDARS), will be reviewed for data extraction for HBV and
 HCV-infected individuals without HIV infection.

 3. The following demographic and clinical data will be retrieved:

 3.1 Date of birth, gender, ethnicity 3.2 Date of diagnosis of HIV infection 3.3 Route of
 transmission of HIV infection 3.4 Other concomitant chronic liver diseases (including
 alcoholic liver disease, fatty liver, autoimmune hepatitis, primary biliary cirrhosis,
 hemochromatosis etc) 3.5 Presence of cirrhosis and cirrhotic complications (including
 ascites, esophageal varices, encephalopathy, hepatorenal syndrome, hepatic coma) 3.6 Other
 comorbidities, including diabetes mellitus, drug-induced hepatitis, alcoholism 3.7 History of
 AIDS-defining illness 3.8 Nadir CD4 count, latest CD4 count 3.9 Latest HIV viral load 3.10
 Bilirubin, ALT, ALP, total protein, albumin, platelet count, prothrombin time 3.11 HBeAg,
 anti-HBe, HBV DNA, HCV RNA 3.12 Antiviral therapy for HIV, HBV and HCV, including date of
 initiation and cessation, and name of drugs prescribed 3.13 Date of last follow-up 3.14 Date
 of diagnosis of liver cancer 3.15 Treatment of liver cancer (surgical, locoregional,
 chemotherapy, others) 3.16 Date and cause of death
1. HIV-infected individuals with and without HBV or HCV co-infection:

 Inclusion criteria:

 -  Positive HIV antibody

 -  At least one visit in one of the HIV clinics

 -  Subjects with positive HBsAg and/or anti-HBc will be regarded as having HBV
 co-infection

 -  Subjects with positive HCV antibody will be regarded as having HCV co-infection

 Exclusion criteria:

 -nil

 2. HBV/HCV mono-infected individuals:

 Inclusion criteria:

 -  Documented diagnosis of hepatitis B or hepatitis C infection, or

 -  Positive HBsAg and/or anti-HBc, or

 -  Positive HCV antibody, and

 -  Negative HIV antibody result, or no record of HIV diagnosis or anti-retroviral therapy
 prescription

 Exclusion criteria:

 - nil